The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCOS.L Share News (COS)

  • There is currently no data for COS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Collagen Expects Widened Annual Loss On Higher Contract Costs

Wed, 18th Mar 2020 18:49

(Alliance News) - Collagen Solutions PLC, a developer and manufacturer of biomaterials for the enhancement and extension of human life, on Wednesday said loss for the year to March-end will be materially greater than anticipated due to increased costs from a development and manufacturing contract which has taken longer than originally anticipated.

The company expects to record a one-time write down of GBP900,000 relating to the delayed contract. It also expects delays in certain contracts to impact annual revenue.

In financial 2019, the company recorded a pretax loss of GBP1.8 million and revenue of GBP4.5 million.

On Covid-19 outbreak, the company said it has put in place health and safety measures aligned with the government and industry recommendations. This includes a suspension of all non-essential travel, flexibility for employees faced with indirect effects of these measures, and of course a requirement to remain at home for any sick employees.

Shares in Collagen Solutions closed 44% lower at 1.10 pence each in London on Wednesday.

By Tapan Panchal; tapanpanchal@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
7 Jul 2015 05:20

Earnings, Trading Statements Calendar - Week Ahead

Read more
6 Jul 2015 15:03

Earnings, Trading Statements Calendar - Week Ahead

Read more
26 Jun 2015 16:14

Collagen Solutions appoints Panmure as sole broker

Collagen Solutions has appointed Panmure Gordon as its exclusive broker and nominated advisor. The biomaterials manufacturer also granted Panmure with 1.7m new shares via warrant, at a fixed price of 30p per share. The warrants are valid for three years. Panmure will replace Zeus Capital as nominat

Read more
22 Jun 2015 08:15

Collagen Solutions Gets Innovate UK Grant For Electrospinning Project

Read more
28 May 2015 08:23

Collagen Solutions Subsidiary Gets US Biomaterial Patent

Read more
27 Apr 2015 08:33

BROKER RATINGS SUMMARY: RBC Upgrades Sports Direct And Supergroup

Read more
13 Mar 2015 13:52

UK DIRECTOR DEALINGS SUMMARY: Reed Elsevier CEO Sells Shares And ADRs

Read more
10 Mar 2015 15:15

DIRECTOR DEALINGS: Collagen Solutions Chairman Buys 250,000 Shares

Read more
10 Mar 2015 12:42

UK MIDDAY BRIEFING: The Man From The Pru To Leave On High Note

Read more
10 Mar 2015 12:05

UK WINNERS & LOSERS: Oil Stocks, Gold Miners Hit By Price Weakness

Read more
10 Mar 2015 10:02

Collagen Solutions Expects Revenue To Miss Market Expectations

Read more
5 Jan 2015 10:34

Collagen Solutions signs agreement with Globus Medic

Medical grade collagen components developer Collagen Solutions announced it had agreed a deal with US-based Globus Medic. Under the agreement, the group will supply fibrous collagen powder for use in the manufacture of Globus' bone grafting products. "Globus utilising our fibrous collagen powder is

Read more
17 Oct 2014 08:25

Collagen, Jellagen To Work Together On Getting Collagen From Jellyfish

Read more
27 Aug 2014 07:38

UK MORNING BRIEFING: Shares Open Flat To Higher But Foxtons Falls

Read more
27 Aug 2014 05:53

UK AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.